AAAAAA

   
Results: 1-12 |
Results: 12
Diazepam inhibits HIV-1 Tat-induced migration of human microglia
Authors: Lokensgard, JR Hu, SX Hegg, CC Thayer, SA Gekker, G Peterson, PK
Citation: Jr. Lokensgard et al., Diazepam inhibits HIV-1 Tat-induced migration of human microglia, J NEUROVIRO, 7(5), 2001, pp. 481-486
Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: Antiviral implications
Authors: Cheeran, MCJ Hu, SX Yager, SL Gekker, G Peterson, PK Lokensgard, JR
Citation: Mcj. Cheeran et al., Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: Antiviral implications, J NEUROVIRO, 7(2), 2001, pp. 135-147
Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4(+) lymphocyte cultures
Authors: Gekker, G Lokensgard, JR Peterson, PK
Citation: G. Gekker et al., Naltrexone potentiates anti-HIV-1 activity of antiretroviral drugs in CD4(+) lymphocyte cultures, DRUG AL DEP, 64(3), 2001, pp. 257-263
U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages
Authors: Chao, CC Gekker, G Sheng, WS Hu, SX Peterson, PK
Citation: Cc. Chao et al., U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages, DRUG AL DEP, 62(2), 2001, pp. 149-154
Immunofluorescence detection of delta opioid receptors (DOR) on human peripheral blood CD4(+) T cells and DOR-dependent suppression of HIV-1 expression
Authors: Sharp, BM McAllen, K Gekker, G Shahabi, NA Peterson, PK
Citation: Bm. Sharp et al., Immunofluorescence detection of delta opioid receptors (DOR) on human peripheral blood CD4(+) T cells and DOR-dependent suppression of HIV-1 expression, J IMMUNOL, 167(2), 2001, pp. 1097-1102
kappa-opioid receptor agonist suppression of HIV-1 expression in CD4(+) lymphocytes
Authors: Peterson, PK Gekker, G Lokensgard, JR Bidlack, JM Chang, AC Fang, XG Portoghese, PS
Citation: Pk. Peterson et al., kappa-opioid receptor agonist suppression of HIV-1 expression in CD4(+) lymphocytes, BIOCH PHARM, 61(9), 2001, pp. 1145-1151
CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes
Authors: Cheerin, MCJ Gekker, G Hu, SX Yager, SL Peterson, PK Lokensgard, JR
Citation: Mcj. Cheerin et al., CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes, CL DIAG LAB, 7(4), 2000, pp. 710-713
U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression
Authors: Chao, CC Hu, SX Gekker, G Lokensgard, JR Heyes, MP Peterson, PK
Citation: Cc. Chao et al., U50,488 protection against HIV-1-related neurotoxicity: involvement of quinolinic acid suppression, NEUROPHARM, 39(1), 2000, pp. 150-160
Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes
Authors: Cheeran, MCJ Hu, SX Gekker, G Lokensgard, JR
Citation: Mcj. Cheeran et al., Decreased cytomegalovirus expression following proinflammatory cytokine treatment of primary human astrocytes, J IMMUNOL, 164(2), 2000, pp. 926-933
Human cytomegalovirus replication and modulation of apoptosis in astrocytes
Authors: Lokensgard, JR Cheeran, MCJ Gekker, G Hu, SX Chao, CC Peterson, PK
Citation: Jr. Lokensgard et al., Human cytomegalovirus replication and modulation of apoptosis in astrocytes, J HUMAN VIR, 2(2), 1999, pp. 91-101
CD8(+) lymphocyte-mediated suppression of human immunodeficiency virus type 1 expression in human brain cells
Authors: Lokensgard, JR Gekker, G Hu, SX Chao, CC Simpson, M Schut, RL Peterson, PK
Citation: Jr. Lokensgard et al., CD8(+) lymphocyte-mediated suppression of human immunodeficiency virus type 1 expression in human brain cells, IMMUNOL LET, 67(3), 1999, pp. 257-261
Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor
Authors: Peterson, PK Gekker, G Hu, SX Lokensgard, J Portoghese, PS Chao, CC
Citation: Pk. Peterson et al., Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor, NEUROPHARM, 38(2), 1999, pp. 273-278
Risultati: 1-12 |